Centene Expects To Reaffirm 2024 Adjusted EPS Guidance Of Greater Than $6.80 (Est $6.82) At Investors Meet On Sept. 17, 2024 And Bank Of America 2024 Global Healthcare Conference - Filing
Portfolio Pulse from Benzinga Newsdesk
Centene is set to reaffirm its 2024 adjusted EPS guidance of over $6.80 at an upcoming investor meeting and the Bank of America 2024 Global Healthcare Conference.
September 16, 2024 | 8:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Centene plans to reaffirm its 2024 adjusted EPS guidance of greater than $6.80, aligning with market estimates. This announcement will be made at an investor meeting and the Bank of America 2024 Global Healthcare Conference.
Centene's reaffirmation of its EPS guidance suggests confidence in its financial performance, which is likely to positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100